Literature DB >> 6466345

Toxicity of heparin in isolated rat hepatocytes.

S W Sanders, G E Dukes, P Gray, K G Tolman.   

Abstract

The effect of heparin on isolated rat hepatocytes in monolayer culture was assessed to investigate the observed increase in serum aminotransferase activity in patients treated with heparin for thromboembolic disorders. Cells were treated with porcine intestinal mucosal heparin or beef lung heparin in concentrations ranging from 0.01 to 100 units/ml. Toxicity was evaluated based on cell damage or death measured by LDH release into the culture media as a fraction of total system LDH (LDH index). Toxicity appeared at concentrations between 1 and 10 units/ml (P less than 0.05). The uptake and binding of heparin by the hepatocyte were evaluated by addition of tritium-labeled heparin to the cultures. Sucrose gradient centrifugation with isolation of the liver plasma membranes (LPM) showed little membrane binding of heparin. The majority of intracellular heparin was located in the cytosol fraction. Heparin gains access to hepatocytes and causes a dose-related toxic effect resulting in cell damage and death. This investigation indicates that the increased serum aminotransferase concentrations seen with heparin treatment may be due to a direct hepatotoxic effect of heparin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466345     DOI: 10.1016/0006-2952(84)90658-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury.

Authors:  Yong Sun; Li-Yong Pu; Ling Lu; Xue-Hao Wang; Feng Zhang; Jian-Hua Rao
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

2.  The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.

Authors:  A H Harrill; J Roach; I Fier; J S Eaddy; C L Kurtz; D J Antoine; D M Spencer; T K Kishimoto; D S Pisetsky; B K Park; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2012-06-27       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.